BGI-Research is one of the top ten basic research institutions in Shenzhen. After years of dedication in genomic research, BGI-Research has become a world-leading research center. Focusing on developing gene reading, writing and storage technologies, and leading international big data and disease prevention mega-science programs, BGI-Research aims to establish a comprehensive scientific research system covering bioinformatics, human genomics, agricultural genomics, microbiology, and marine biology.

Established in 2011, BGI College leverages BGI’s comprehensive “industry-academia-research” platform with big data, big science, big industry, and big health. Emphasizing "talent cultivation through project-driven practice." Establish an innovation platform that is complementary to current life science education. BGI College has developed a talent training model that keeps pace with the evolution of genomic science. Consequently, the institution has produced innovative and top-notch talents who can lead the scientific advancement of life and the development of strategic emerging industries.

China National GeneBank (CNGB) is one of the key science infrastructures in Shenzhen, approved and funded by the Chinese government. CNGB is committed to supporting public welfare, life science research, innovation and industry development, through effective bioresource conservation, digitalization and utilization. CNGB is owned by the government and operated independently by BGI-Research under the guidance and supervision of State High-Tech Industrial Innovation Center, Shenzhen (HIIC).

Shenzhen Mammoth Foundation is the first public welfare foundation in China that promotes gene technology for the benefit of people's livelihood. With the mission of “Being good to the world and letting gene technology benefit everyone”, the foundation advocates and develops gene technology that is people-oriented, equal and universal, convenient and accessible as the principle, and focuses on medical care, education, and cross-border exchanges as the main working area.

GigaScience Press is the publishing arm of BGI, showcasing the latest technologies and standards in science dissemination, making Open Science the primary goal for its publications and outputs. The Press currently publishes two scientific journals: GigaScience and GigaByte. Both journals are online and open access, with the goal of democratizing science communication to better reach researchers around the globe. The Press also runs a data publishing platform, GigaDB, with an in-house data curation team supports reproducibility, reusability and the FAIR principles of data stewardship.

BGI Genomics (Shenzhen Stock Exchange: 300676) is the world's leading integrated solutions provider of scientific technology services and precision medicine, to research institutions, enterprises, medical facilities, and public health organizations. Relying on cutting-edge sequencing and bioinformatics technology, BGI Genomics' mission is to drive technological advancement, mitigate birth defects, combat tumors, and safeguard against serious illnesses through our commitment to advancing precision medicine.

MGI Tech (Shanghai Stock Exchange: 688114) (hereafter as MGI) is committed to building core tools and technology to lead life science through intelligent innovation. With a focus on R&D, production and sales of DNA sequencing instruments, reagents, and related products, MGI provides real-time, panoramic, and full-life-cycle equipment and systems for precision medicine, precision agriculture, precision healthcare and other relevant industries. MGI is a leading producer of clinical high-throughput gene sequencers, and its multi-omics platforms include genetic sequencing, medical imaging, and laboratory automation.

BGI Bioverse adheres to the tenet of “Harmony among nature, earth and mankind, everything coexists”, relying on the advantages of BGI's multi-omics big data platform, it innovates technologies such as whole-genome design breeding, gene editing, and synthetic biology to quickly and accurately cultivate new super agricultural varieties and microbial inoculant products, and integrated the "Sand Mask" technology to transform deserts into green ecological and a new carrier of green ecology and agricultural planting, to realize the coordinated development of "Natural and Earth".

BGI Nutrition focus on research of human symbiotic microbiota for 17 years, is the hard core that runs through science, technology, and industry in this field. Based on the global leading scientific research achievements of BGI Group in the field of human symbiotic microbiota, and with a rich collection of over 50,000 strains of human symbiotic microbiota, we continue to build a complete industrial chain from human microbiota detection to functional probiotic intervention, and then to nutritional and health services.

FGI specializes in innovative applications and research of omics-based identification technologies across multi-dimensional scenarios, spanning forensic science, food safety, plant and animal species identification, and beyond. Adhering to the principles of fairness, rigor, and scientific integrity, FGI is committed to providing accurate scientific identification evidence and cutting-edge tools and platforms to ensure that its self-innovated technologies better serve society and contribute to the public welfare.

BGI Cell leads the health industry by exploiting the advantage of “Gene + Cell” trans-omics platform while providing lifelong health management solutions through advanced technology and excellent service. With Shenzhen as its headquarters, BGI Cell has established cell preparation centers in Hebei, Shandong, Zhejiang and other provinces and cities, and the cell storage service radiates the whole country.